2025

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany
Elamouri F, Lutz T, Knecht G, Wyen C, Posdzich P, Monin M, Sabranski M, Hoffmann C, Killer A, Jensen B, Malin J, Esser S, Mauss S, Vogelmann R, Boesecke C, Beer D, Grunwald S, Haberl A, Voit F, Qurishi N, Noe S, Khaykin P, Schneeweiß S, Christensen S, Schwarze-Zander C, Jessen A, Boyd A, Rockstroh J, van Bremen K
INFECTION. 2025 [Epub ahead of print].

Respiratory syncytial virus infection in patients with haematological diseases: a retrospective multicentre study
Herrmann S, Graefe S, Christopeit M, Sonnemann P, Hattenhauer T, Mispelbaum R, Monin M, Orth H, Glasshove C, Gruell H, Klein F, Klein U, Lehmann C, Naendrup J, Stemler J, Salmanton-Garcia J, Markus T, Cornely O, Mellinghoff S
INFECTION. 2025;53(4):1341-1350.

Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIV
Mispelbaum R, Hattenhauer T, Hoffmann C, Lehmann C, Bauernfeind F, Brossart P, Christopeit M, Alsdorf W, Bokemeyer C, Layer J, Roider J, Hentrich M, Monin M
HIV MED. 2025 [Epub ahead of print].

Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study
Möhring C, Berger M, Sadeghlar F, Zhou X, Zhou T, Monin M, Shmanko K, Welland S, Sinner F, Schwacha-Eipper B, Bauer U, Roderburg C, Pirozzi A, Ben Khaled N, Schrammen P, Balcar L, Pinter M, Ettrich T, Saborowski A, Berres M, De Toni E, Lüdde T, Rimassa L, Ehmer U, Venerito M, Radu I, Schmidt-Wolf I, Weinmann A, Vogel A, Schmid M, Kalff J, Strassburg C, Gonzalez-Carmona M
CANCERS. 2025;17(6):.

2024

Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures
Gonzalez-Carmona M, Schmitz A, Berger M, Baier L, Gorny J, Sadeghlar F, Anhalt T, Zhou X, Zhou T, Mahn R, Möhring C, Linnemann T, Schmid M, Strassburg C, Boesecke C, Rockstroh J, Eis-Hübinger A, Monin M
INT J MOL SCI. 2024;25(24):13613.

First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison
Mahn R, Glüer O, Sadeghlar F, Möhring C, Zhou T, Anhalt T, Monin M, Kania A, Glowka T, Feldmann G, Brossart P, Kalff J, Schmidt-Wolf I, Strassburg C, Gonzalez-Carmona M
J HEPATOCELL CARCINO. 2024;11:81-94.

A fatal course of COVID-19 during the Omicron surge: can you estimate your patients' SARS-CoV-2 immune status?
Mersch M, Schlabe S, Breitschwerdt S, Laufenberg J, Emmert D, Aldabbagh S, Boesecke C, Monin M
INFECTION. 2024;52(1):271-273.

Early combination therapy of COVID-19 in high-risk patients
Orth H, Flasshove C, Berger M, Hattenhauer T, Biederbick K, Mispelbaum R, Klein U, Stemler J, Fisahn M, Doleschall A, Baermann B, Koenigshausen E, Tselikmann O, Killer A, de Angelis C, Gliga S, Stegbauer J, Spuck N, Silling G, Rockstroh J, Strassburg C, Brossart P, Panse J, Jensen B, Luedde T, Boesecke C, Heine A, Cornely O, Monin M
INFECTION. 2024;52(3):877-889.

The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Praktiknjo M, Pena Solano A, Sadeghlar F, Welchowski T, Schmid M, Möhring C, Zhou T, Mahn R, Monin M, Meyer C, Feldmann G, Brossart P, van Beekum C, Semaan A, Matthaei H, Manekeller S, Sprinkart A, Nowak S, Luetkens J, Kalff J, Strassburg C, González-Carmona M
SCI REP-UK. 2024;14(1):22146.

HIV Care in Ukrainian Migrants in Two European Countries: All the Same?
van Bremen K, Parczewski M, Monin M, Leszczyszyn-Pynka M, Schlabe S, Lenkiewicz F, Karasińska-Cieślak M, Wasmuth J, Witak-Jędra M, Breitschwerdt S, Rockstroh J, Zhyvytsia D, Boesecke C, Chober D, Aksak-Wąs B
PATHOGENS. 2024;13(8):.

2023

Enabling CAR T-cell therapies for HIV-positive lymphoma patients - A call for action
Hattenhauer S, Mispelbaum R, Hentrich M, Boesecke C, Monin M
HIV MED. 2023;24(9):957-964.

Tecovirimat for the treatment of severe Mpox in Germany
Hermanussen L, Brehm T, Wolf T, Boesecke C, Schlabe S, Borgans F, Monin M, Jensen B, Windhaber S, Scholten S, Jordan S, Lütgehetmann M, Wiesch J, Addo M, Mikolajewska A, Niebank M, Schmiedel S
INFECTION. 2023;51(5):1563-1568.

Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany
Hoffmann C, Jessen H, Wyen C, Grunwald S, Noe S, Teichmann J, Krauss A, Kolarikal H, Scholten S, Schuler C, Bickel M, Roll C, Kreckel P, Köppe S, Straub M, Klausen G, Lenz J, Esser S, Jensen B, Rausch M, Unger S, Pauli R, Härter G, Müller M, Masuhr A, Schäfer G, Seybold U, Schellberg S, Schneider J, Monin M, Wolf E, Spinner C, Boesecke C
HIV MED. 2023;24(4):389-397.

Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?
Hübner Y, Spuck N, Berger M, Schlabe S, Rieke G, Breitschwerdt S, van Bremen K, Strassburg C, Gonzalez-Carmona M, Wasmuth J, Rockstroh J, Boesecke C, Monin M
INFECTION. 2023;51(6):1855-1861.

Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real-world cohort
Möhring C, Mańczak A, Timotheou A, Sadeghlar F, Zhou T, Mahn R, Monin M, Toma M, Feldmann G, Brossart P, Köksal M, Sarria G, Sommer N, Lingohr P, Jafari A, Kalff J, Strassburg C, Gonzalez-Carmona M
INT J CANCER. 2023;153(3):609-622.

Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?
Möhring C, Timotheou A, Mańczak A, Sadeghlar F, Zhou T, Mahn R, Bartels A, Monin M, Toma M, Feldmann G, Brossart P, Köksal M, Sarria G, Giordano F, Lingohr P, Jafari A, Kalff J, Strassburg C, Gonzalez-Carmona M
J CANCER RES CLIN. 2023;149(5):1849-1862.

SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination
Monin M, Baier L, Berger M, Gorny J, Zhou T, Mahn R, Sadeghlar F, Möhring C, van Bremen K, Boesecke C, Rockstroh J, Strassburg C, Eis-Hübinger A, Gonzalez-Carmona M
GUT. 2023;72(6):1227-1229.

Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients
Monin M, Baier L, Gorny J, Berger M, Zhou T, Mahn R, Sadeghlar F, Möhring C, Boesecke C, van Bremen K, Rockstroh J, Strassburg C, Eis-Hübinger A, Schmid M, Gonzalez-Carmona M
LIVER CANCER. 2023;12(4):339-355.

Impaired immunogenicity after vaccination for SARS-CoV-2 in patients with gastrointestinal cancer: does tumor entity matter?
Monin M, Gorny J, Berger M, Baier L, Zhou T, Mahn R, Sadeghlar F, Möhring C, Boesecke C, van Bremen K, Rieke G, Schlabe S, Breitschwerdt S, Marinova M, Schmidt-Wolf I, Strassburg C, Eis-Hübinger A, Gonzalez-Carmona M
J GASTROINTEST ONCOL. 2023;14(3):1218-1234.

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)
Monin M, Ingiliz P, Lutz T, Scholten S, Cordes C, Martínez-Rebollar M, Spinner C, Nelson M, Rausch M, Bhagani S, Peters L, Reiberger T, Mauss S, Rockstroh J, Boesecke C
CLIN INFECT DIS. 2023;76(3):e607-e612.

2022

Severe monkeypox-virus infection in undiagnosed advanced HIV infection
Boesecke C, Monin M, van Bremen K, Schlabe S, Hoffmann C
INFECTION. 2022;50(6):1633-1634.

SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness
Monin M, Marx B, Meffert L, Boesecke C, Rockstroh J, Strassburg C, Brossart P, Heine A
ANN HEMATOL. 2022;101(9):2089-2090.

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination
Rieke G, van Bremen K, Bischoff J, ToVinh M, Monin M, Schlabe S, Raabe J, Kaiser K, Finnemann C, Odainic A, Kudaliyanage A, Latz E, Strassburg C, Boesecke C, Schmidt S, Krämer B, Rockstroh J, Nattermann J
J INFECT DIS. 2022;225(10):1688-1693.

Impact of COVID-19 on HIV late diagnosis in a specialized German centre
van Bremen K, Monin M, Schlabe S, Bischoff J, Rieke G, Schwarze-Zander C, Wasmuth J, Rockstroh J, Boesecke C
HIV MED. 2022;23(11):1209-1213.

2021

Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, Schulte-Schrepping J, Kaiser K, Rieke G, Bischoff J, Monin M, Hoffmeister C, Schlabe S, De Domenico E, Reusch N, Händler K, Reynolds G, Blüthgen N, Hack G, Finnemann C, Nischalke H, Strassburg C, Stephenson E, Su Y, Gardner L, Yuan D, Chen D, Goldman J, Rosenstiel P, Schmidt S, Latz E, Hrusovsky K, Ball A, Johnson J, Koenig P, Schmidt F, Haniffa M, Heath J, Kümmerer B, Keitel V, Jensen B, Stubbemann P, Kurth F, Sander L, Sawitzki B, Aschenbrenner A, Schultze J, Nattermann J
IMMUNITY. 2021;54(11):2650-2669.e14.

Cardiac MRI in Suspected Acute COVID-19 Myocarditis
Luetkens J, Isaak A, Öztürk C, Mesropyan N, Monin M, Schlabe S, Reinert M, Faron A, Heine A, Velten M, Dabir D, Boesecke C, Strassburg C, Attenberger U, Zimmer S, Duerr G, Nattermann J
RADIOL-CARDIOTHORAC. 2021;3(2):e200628.

SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)
van Bremen K, Monin M, Eis-Hübinger A, Marx B, Aldabaggh S, Streeck H, Wasmuth J, Menting T, Schlabe S, Rieke G, Schwarze-Zander C, Rockstroh J, Boesecke C
INFECTION. 2021;49(5):1039-1043.

2016

The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway
Monin M, Krause P, Stelling R, Bocuk D, Niebert S, Klemm F, Pukrop T, Koenig S
J SURG RES. 2016;203(1):193-205.

Letzte Aktualisierung aus dem FIS: 24.11.2025 - 00:34 Uhr